Decreased nocturnal synthesis of melatonin in patients with coronary artery disease

International Journal of Cardiology

Volumn 89, Issue 1, 2003, Pages 103-107

  Yaprak, Mevlut ^a   Altun, Armagan ^a,b   Vardar, Arzu ^a   Aktoz, Meryem ^a   Ciftci, Sukran ^a   Ozbay, Gultac ^a  

^a TRAKYA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Coronary artery disease; Melatonin; Sympathetic activation

Indexed keywords

MELATONIN;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; BLOOD SAMPLING; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0242548489     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(02)00461-8     Document Type: Article

References (22)

1. Panza J.A., Epstein S.E., Quyyumi A.A. Circadian variation in vascular tone and its relation to α-sympathetic vasoconstrictor activity. N Engl J Med. 325:1991;986-990.
2. Burgess H.J., Trinder J., Kim Y., Luke D. Sleep and circadian influences on cardiac autonomic nervous system activity. Am J Physiol. 273:1997;H1761-H1768.
3. Linsell C.R., Lightman S.L., Mullen P.E., Brown M.J., Causon R.C. Circadian rhythms of epinephrine and norepinephrine in man. J Clin Endocrinol Metab. 60:1985;1210-1215.
4. Huikuri H.V., Linnaluoto M.K., Seppanen T., Airaksinen K.E., Kessler K.M., Takkunen J.T., Myerburg R.J. Circadian rhythm of heart rate variability in survivors of cardiac arrest. Am J Cardiol. 70:1992;610-615.
5. Verdecchia P., Schillaci G., Gatteschi C., Zampi I., Battistelli M., Bartoccini C., Porcellati C. Blunted nocturnal fall in blood pressure in hypertensive women with future cardiovascular morbid events. Circulation. 88:1993;986-992.
6. Muller J.E. Circadian variation and triggering of acute coronary events. Am Heart J. 137:1999;S1-S8.
7. Cagnacci A., Arangio S., Angiolucci M., Maschio E., Melis G.B. Influences of melatonin administration on the circulation of women. Am J Physiol. 274:1998;R335-R338.
8. Arangino S., Cagnacci A., Angiolucci M., Vacca A.M., Longu G., Volpe A., Melis G.B. Effects of melatonin on vascular reactivity, catecholamine levels, and blood pressure in healthy men. Am J Cardiol. 83:1999;1417-1419.
9. Nishiyama K., Yasue H., Moriyama Y., Tsunoda R., Ogawa H., Yoshimura M., Kugiyama K. Acute effects of melatonin administration on cardiovascular autonomic regulation in healthy men. Am Heart J. 141:2001;e9.
10. Brugger P., Marktl W., Herold M. Impaired nocturnal secretion of melatonin in coronary heart disease. Lancet. 345:1995;1408.
11. Sakotnik A., Liebmannt P.M., Stoschitzky K., Lercher P., Schauenstein K., Klein W., Eber B. Decreased melatonin synthesis in patients with coronary artery disease. Eur Heart J. 20:1999;1314-1317.
12. Girotti L., Lago M., Ianovsky O., Carbajaler J., Elizari M.V., Brusco L.I., Cardinali D.P. Low urinary 6-sulphatoxymelatonin levels in patients with coronary artery disease. J Pineal Res. 29:2000;138-142.
13. Nagtegaal E., Smits M., Swart W., van der Meer G., Kerkhof G. Melatonin secretion and coronary heart disease. Lancet. 346:1995;1299.
14. Fourtillan J.B., Brisson A.M., Fourtillan M., Ingrand I., Decourt J.P., Girault J. Melatonin secretion occurs at a constant rate in both young and older men and women. Am J Physiol Endocrinol Metab. 280:2001;E11-E22.
15. Penev P.D., Zee P.C. Melatonin: A clinical perspective. Ann Neurol. 42:1997;545-553.
16. Reiter R.J. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocrinol Rev. 12:1991;151.
17. Stoschitzky K., Sakotnik A., Lercher P., Zwiker R., Maier R., Liebmann P., Lindner W. Influence of beta-blockers on melatonin release. Eur J Clin Pharmacol. 55:1999;111-115.
18. Remme W.J. The sympathetic nervous system and ischaemic heart disease. Eur Heart J. 19:1998;F62-F71.
19. Demitrack M.A., Lewy A.J., Reus V.I. Pineal-adrenal interactions: the effect of acute pharmacological blockade of nocturnal melatonin secretion. Psychiatry Res. 32:1990;183-189.
20. Cowen P.J., Bevan J.S., Gosden B., Elliott S.A. Treatment with β-adrenoceptor blockers reduces plasma melatonin concentration. Br J Pharmacol. 19:1985;258-260.
21. Touitou Y., Bogdan A., Claustrat B., Touitou C. Drugs affecting melatonin secretion in man. Trentini G.P., DeGaetani C., Pevet P. Fundamentals and clinics in pineal research. 1987;349-356 Serono Symposia Publications, Raven Press, New York.
22. Zeitzer J.M., Daniels J.E., Duffy J.F., Klerman E.B., Shanahan T.L., Dijk D.J., Czeisler C.A. Do plasma melatonin concentrations decline with age? Am J Med. 107:1999;432-436.